USPTO 2015–2025 USPTO PatentsView US Corporation

Trisalus Life Sciences, Inc.

USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

24.8

Avg claims per patent

5-year filing velocity

The verdict

Trisalus holds 10 US patents across 10 technology areas, rank #27,684 of 50,000 tracked assignees.

#27,684
of 50,000 US assignees by volume: Top 8%
by Innovation Score (54.3/100): 24.8
avg claims per patent

Portfolio overview

Trisalus Life Sciences, Inc. has been granted 10 US utility patents between 2022 and 2025, placing Trisalus Life Sciences, Inc. at rank #27,684 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.8 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Trisalus Life Sciences, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Trisalus sits between Transhield, Inc. (10 patents, rank #27,680) and Tritec Marine Ltd. (10 patents, rank #27,688) - the closest US assignees by grant volume. The composite Innovation Score of 54.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Trisalus Life Sciences, Inc.'s 24.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Trisalus Life Sciences, Inc. against peers pursuing similar technology classes.

Transhield

10
Travel Tags

10
Travelers Club Lu…

10
Tripath Imaging

10
Triangle Brass Ma…

10
Triax

10
Trifacta

10
Tritec Marine

10
Trisalus Life Sci… ◀

10

What this shows Trisalus holds 10 patents at rank #27,684, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Trisalus

By rank, the assignees closest to #27,684 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Trisalus's primary technology class.

Trisalus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Trisalus Life Sciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	3	30.0%
2023	1	10.0%
2024	2	20.0%
2025	4	40.0%

Which technologies does Trisalus Life Sciences, Inc. patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 8

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 7

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 6

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 3

B05D - PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

C07K - PEPTIDES 1

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Where it ranks

Overall rank by patents

#27,684

Across all tracked assignees

Innovation Score

54.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Trisalus Life Sciences, Inc. hold?

Trisalus Life Sciences, Inc. holds 10 US granted patents filed between 2022 and 2025, spanning 10 technology areas.

What is Trisalus Life Sciences, Inc.'s Innovation Score?

Trisalus Life Sciences, Inc. has an Innovation Score of 54.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Trisalus Life Sciences, Inc. focus on?

Trisalus Life Sciences, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 8 patents. The company has filed patents in 10 CPC subclasses total.

Is Trisalus Life Sciences, Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Trisalus Life Sciences, Inc..

What does claim depth mean for Trisalus Life Sciences, Inc.'s patents?

Trisalus Life Sciences, Inc.'s patents average 24.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Trisalus Life Sciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Trisalus's 10 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Trisalus ranks #27,684 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.